Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 6 Terminated 5 Recruiting 4 Completed 4 Unknown 3 Withdrawn 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 109 Uterine Cervical Neoplasms 57 Endometrial Neoplasms 38 Fallopian Tube Neoplasms 34 Carcinoma, Ovarian Epithelial 27 Breast Neoplasms 25 Neoplasms 15 Carcinoma, Non-Small-Cell Lung 13 Pancreatic Neoplasms 12 Uterine Cervical Dysplasia 11 Recurrence 11 Stomach Neoplasms 10 Neoplasm Metastasis 10 Lung Neoplasms 9 Colorectal Neoplasms 9 Uterine Neoplasms 8 Triple Negative Breast Neoplasms 8 Sarcoma 8 Urinary Bladder Neoplasms 7 Melanoma 6 Esophageal Neoplasms 6 Vulvar Neoplasms 5 Vaginal Neoplasms 5 Testicular Neoplasms 5 Lymphoma, Non-Hodgkin 5 Small Cell Lung Carcinoma 4 Sezary Syndrome 4 Rectal Neoplasms 4 Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinosarcoma × Gynecologic × Clear all

NCT03933761 2021-08-10

PRECISE

Australia New Zealand Gynaecological Oncology Group

Phase 2 Withdrawn

GynecologicSarcoma

Carcinosarcoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡